VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, announced that… Read More
In 2019, the Government of Canada released Canada’s first national dementia strategy to address the significant and growing impact of dementia on people in Canada. With funding from the Canadian… Read More
In Canada, one out of twelve people—many of whom are children—has a rare disease. There are thousands of different rare diseases that affect patients, their families and caregivers across the… Read More
VANCOUVER, BC — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced that management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference:… Read More
VANCOUVER, BC — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced it will report its third quarter 2023 financial and operating results after the close of U.S. financial markets… Read More
